These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 18271300

  • 1. Mathematical evaluation of similarity factor using various weighing approaches on aceclofenac marketed formulations by model-independent method.
    Soni TG, Desai JU, Nagda CD, Gandhi TR, Chotai NP.
    Pharmazie; 2008 Jan; 63(1):31-4. PubMed ID: 18271300
    [Abstract] [Full Text] [Related]

  • 2. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P, Antoniella E, Valvo L, Alimonti S, Memoli A.
    J Pharm Biomed Anal; 2005 Apr 01; 37(4):679-85. PubMed ID: 15797788
    [Abstract] [Full Text] [Related]

  • 3. Quality surveillance of immediate release aceclofenac tablets (100 mg) available in local market.
    Bushra R, Shoaib MH, Ali H, Shafiq Y, Zafar F, Alam S, Aslam N.
    Pak J Pharm Sci; 2017 Nov 01; 30(6):2193-2201. PubMed ID: 29175789
    [Abstract] [Full Text] [Related]

  • 4. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May 01; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 5. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G, Wedemeyer RS, Nagel S, Giessmann T, Mönnikes H, Wilson CG, Siegmund W, Weitschies W.
    Eur J Pharm Biopharm; 2008 Oct 01; 70(2):421-8. PubMed ID: 18582568
    [Abstract] [Full Text] [Related]

  • 6. In vitro determination of aceclofenac Mouth Dissolving Tablets.
    Shobhit S, Gupta SK.
    Polim Med; 2013 Oct 01; 43(4):227-9. PubMed ID: 24596037
    [Abstract] [Full Text] [Related]

  • 7. A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
    Maggio RM, Castellano PM, Kaufman TS.
    Eur J Pharm Sci; 2008 May 10; 34(1):66-77. PubMed ID: 18394869
    [Abstract] [Full Text] [Related]

  • 8. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N.
    Eur J Pharm Biopharm; 2008 Oct 10; 70(2):674-83. PubMed ID: 18606224
    [Abstract] [Full Text] [Related]

  • 9. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
    Qureshi J, Ahuja A, Baboota S, Chutani K, Jain S, Ali J.
    Methods Find Exp Clin Pharmacol; 2009 Oct 10; 31(1):15-23. PubMed ID: 19357794
    [Abstract] [Full Text] [Related]

  • 10. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets.
    Petrović J, Ibrić S, Betz G, Parojcić J, Durić Z.
    Eur J Pharm Sci; 2009 Sep 10; 38(2):172-80. PubMed ID: 19632323
    [Abstract] [Full Text] [Related]

  • 11. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG, Chi MH, Kim YI, Woo JS, Park ES.
    Arch Pharm Res; 2008 Dec 10; 31(12):1637-43. PubMed ID: 19099235
    [Abstract] [Full Text] [Related]

  • 12. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
    Bendas ER.
    Arch Pharm Res; 2009 Sep 10; 32(9):1317-29. PubMed ID: 19784589
    [Abstract] [Full Text] [Related]

  • 13. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML, Berry MR, Nickerson B.
    J Pharm Biomed Anal; 2007 May 09; 44(1):79-84. PubMed ID: 17379465
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of a reaction-limited model of dissolution: application to official dissolution tests experiments.
    Dokoumetzidis A, Papadopoulou V, Valsami G, Macheras P.
    Int J Pharm; 2008 May 01; 355(1-2):114-25. PubMed ID: 18206324
    [Abstract] [Full Text] [Related]

  • 16. Statistical method for evaluation of dissolution stability in the formulation development of solid dosage forms: tablets of amonafide.
    Gil-Alegre ME, Bernabeu JA, Camacho MA, Torres-Suarez AI.
    Pharmazie; 2004 Jul 01; 59(7):541-7. PubMed ID: 15296092
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sensitive spectrophotometric determination of aceclofenac following azo dye formation with 4-carboxyl-2,6-dinitrobenzene diazonium ion.
    Aderibigbe SA, Adegoke OA, Idowu OS, Olaleye SO.
    Acta Pol Pharm; 2012 Jul 01; 69(2):203-11. PubMed ID: 22568034
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polarographic behaviour of Aceclofenac, Tenoxicam and Droxicam in a methanol-water mixture.
    Acuña JA, Vázquez MD, Tascón ML, Sánchez-Batanero P.
    J Pharm Biomed Anal; 2004 Sep 21; 36(1):157-62. PubMed ID: 15351060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.